Trial Details
COMPLETEDBasic Information
| Clinical ID | c1708 |
|---|---|
| Identifier | NCT01804166 |
| Trial Title | A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Hepatosplenic T-Cell Lymphoma |
| Interventions | DRUG: Infliximab|DRUG: Golimumab |
Participant Information
| Sponsor | Janssen Scientific Affairs, LLC |
|---|---|
| City | Norfolk |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2013-03-21 |
|---|---|
| Primary Completion Date | 2020-02-28 |
| Completion Date | 2020-02-28 |